Category: Mergers & AcquisitionsSyndicate content

Zimmer, Biomet find buyer for knee, elbow assets

April 23, 2015 by Brad Perriello

Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to satisfy European anti-trust regulators about their pending $13 billion merger.

Zimmer, Biomet find buyer for knee, elbow assets

St. Jude Medical pulls the trigger on Spinal Modulation buy

April 20, 2015 by Brad Perriello

St. Jude Medical says it exercised the buyout option on its deal with Spinal Modulation and its Axium chronic pain device.

St. Jude Medical pulls the trigger on Spinal Modulation buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Feds indict ex-Acclarent execs | The week in medtech M&A

April 15, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Feds slap former Acclarent execs with fraud charges; Zimmer extends deadline for $13B Biomet deal; Big data: IBM enlists Medtronic, J&J, Apple in major healthcare push

Feds slap former Acclarent execs with fraud charges

April 13, 2015 by Brad Perriello

U.S. regulators OK $1.4B Sorin-Cyberonics tie-up

April 14, 2015 by Brad Perriello

U.S. anti-trust regulators approve the pending, $1.4 billion merger of Italy's Sorin Group and Cyberonics.

U.S. regulators OK $1.4B Sorin-Cyberonics tie-up

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Big data: IBM enlists Medtronic, J&J, Apple in major healthcare push

April 14, 2015 by Brad Perriello

IBM unveils a major push to use 'Big Data' and its Watson supercomputer to drive healthcare research and personalized medicine, enlisting Medtronic, Johnson & Johnson and Apple to help.

IBM enlists Medtronic, J&J, Apple in major healthcare push

Zimmer extends deadline for $13B Biomet deal

April 14, 2015 by Brad Perriello

Zimmer Holdings extends the deadline for its $13.4 billion merger with Biomet by 3 months as it waits on the U.S. Federal Trade Commission to approve the deal.

Zimmer extends deadline for $13B Biomet deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Feds slap former Acclarent execs with fraud charges

April 13, 2015 by Brad Perriello

Federal prosecutors charge former Acclarent CEO William Facteau and ex-sales veep Patrick Fabian with fraud and conspiracy for allegedly marketing a sinus device for off-label uses.

Feds slap former Acclarent execs with fraud charges

Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.